Task: Answer the multiple choice question.
Question: Which drug exhibits a 1.353% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
a) Cc1c(Cl)cccc1NC(=O)Cn1cnc(S(=O)(=O)N2CCCC2)c1
b) CN(C(=O)CSc1nnc(-c2c[nH]c3ccccc23)n1C1CC1)C1CCS(=O)(=O)C1
c) O=C(CCN1C(=O)C2CC=C(Cl)CC2C1=O)NC1CCCCC1
Answer: c. O=C(CCN1C(=O)C2CC=C(Cl)CC2C1=O)NC1CCCCC1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
O=C(CCN1C(=O)C2CC=C(Cl)CC2C1=O)NC1CCCCC1
O=C(CCN1C(=O)C2CC=C(Cl)CC2C1=O)NC1CCCCC1
3-(5-chloro-1,3-dioxo-3a,4,7,7a-tetrahydroisoindol-2-yl)-N-cyclohexylpropanamide